Bank of America slides as financials wobble amid private-credit anxiety and renewed tariff uncertainty

Bank of America Corporation (BAC) is down 4.6% today. Here is some analysis on what might have caused this price movement.

Analysis: The move looks primarily macro-driven rather than tied to a single Bank of America headline. Financials have been under pressure as investors reassess credit risk (including private-credit/leveraged-loan concerns) while broader markets digest renewed uncertainty around U.S. tariff policy and its potential impact on growth and loan demand.

Details:

Market commentary has highlighted rising worry that problem loans and credit stress could be building beneath the surface, which can pressure large diversified lenders that are highly sensitive to the economic cycle.

Private-credit contagion fears have been in focus, with investors debating whether stress in private lending could widen spreads and raise loss expectations across credit markets, weighing on bank valuations.

U.S. stocks have recently been hit by fresh tariff-related uncertainty, a backdrop that can drive “risk-off” positioning and reduce appetite for economically sensitive sectors like banks.

This could also be amplified by broad selling in financial-sector products (ETFs) and systematic de-risking, which can mechanically drag down large index constituents such as BAC.

Sources:

Financial Times, Associated Press, Business Insider, MarketWatch

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$BAC Hedge Fund Activity

We have seen 1,694 institutional investors add shares of $BAC stock to their portfolio, and 1,535 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 142,443,052 shares (-76.6%) from their portfolio in Q4 2025, for an estimated $7,834,367,860
BERKSHIRE HATHAWAY INC removed 50,774,078 shares (-8.9%) from their portfolio in Q4 2025, for an estimated $2,792,574,290
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 44,413,993 shares (+7091.3%) to their portfolio in Q4 2025, for an estimated $2,442,769,615
CAPITAL INTERNATIONAL INVESTORS added 42,862,620 shares (+inf%) to their portfolio in Q4 2025, for an estimated $2,357,444,100
CITIGROUP INC removed 29,298,493 shares (-54.9%) from their portfolio in Q4 2025, for an estimated $1,611,417,115
VANGUARD GROUP INC added 23,351,183 shares (+3.7%) to their portfolio in Q4 2025, for an estimated $1,284,315,065
CARDANO RISK MANAGEMENT B.V. added 22,621,546 shares (+914.5%) to their portfolio in Q4 2025, for an estimated $1,244,185,030

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$BAC Congressional Stock Trading

Members of Congress have traded $BAC stock 6 times in the past 6 months. Of those trades, 1 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $BAC stock by members of Congress over the last 6 months:

REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$BAC Analyst Ratings

Wall Street analysts have issued reports on $BAC in the last several months. We have seen 11 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

TD Cowen issued a "Buy" rating on 01/15/2026
Truist Securities issued a "Buy" rating on 01/15/2026
Keefe, Bruyette & Woods issued a "Outperform" rating on 01/15/2026
CICC issued a "Outperform" rating on 01/14/2026
Goldman Sachs issued a "Buy" rating on 01/06/2026
Barclays issued a "Overweight" rating on 01/05/2026
Oppenheimer issued a "Outperform" rating on 11/19/2025

To track analyst ratings and price targets for $BAC, check out Quiver Quantitative's $BAC forecast page.

$BAC Price Targets

Multiple analysts have issued price targets for $BAC recently. We have seen 13 analysts offer price targets for $BAC in the last 6 months, with a median target of $62.0.

Here are some recent targets:

Steven Alexopoulos from TD Cowen set a target price of $64.0 on 01/15/2026
Glenn Schorr from Evercore ISI Group set a target price of $59.0 on 01/15/2026
Betsy Graseck from Morgan Stanley set a target price of $64.0 on 01/15/2026
Scott Siefers from Piper Sandler set a target price of $57.0 on 01/15/2026
John McDonald from Truist Securities set a target price of $60.0 on 01/15/2026
Christopher McGratty from Keefe, Bruyette & Woods set a target price of $63.0 on 01/15/2026
An analyst from CICC set a target price of $62.0 on 01/14/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.